Medtronic (MDT) Depreciation & Amortization (CF) (2014 - 2026)

Medtronic's Depreciation & Amortization (CF) history runs 13 years deep, the most recent figure standing at $749.0 million for Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) rose 9.5% year-over-year to $749.0 million; the TTM figure through Jan 2026 stood at $3.1 billion (up 15.21% YoY), while the FY2025 annual figure was $2.9 billion, up 8.08% from the prior year.
• Depreciation & Amortization (CF) came in at $749.0 million for Q1 2026 at Medtronic, up from $745.0 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $840.0 million in Q2 2025 to a low of $649.0 million in Q1 2024.
• A 5-year average of $694.5 million and a median of $675.0 million in 2024 frame the typical range for Depreciation & Amortization (CF).
• Across the five-year window, Depreciation & Amortization (CF) slipped 4.42% in 2024 and increased 28.44% in 2025, its largest moves.
• Medtronic's Depreciation & Amortization (CF) stood at $671.0 million in 2022, then climbed by 0.15% to $672.0 million in 2023, then rose by 0.45% to $675.0 million in 2024, then climbed by 10.37% to $745.0 million in 2025, then rose by 0.54% to $749.0 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $749.0 million, $745.0 million, and $748.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison